Results 1 to 10 of about 117,196 (345)

Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark [PDF]

Acta Dermato-Venereologica
The emergence of new systemic treatments for alopecia areata underscores the importance of estimating rates of potential treatment safety events among individuals with alopecia areata.
Sissel Brandt Toft Sørensen, Prethibha George, Oladayo Jagun, Robert Wolk, Lynne Napatalung, Samuel H. Zwillich, Lars Iversen, Vera Ehrenstein   +7 more
doaj   +2 more sources

Androgenetic Alopecia: Therapy Update

Drugs, 2023
Androgenetic alopecia (AGA), also known as male pattern hair loss (MPHL) or female pattern hair loss (FPHL), is the most common form of alopecia worldwide, and arises from an excessive response to androgens.
S. Devjani, O. Ezemma, K. Kelley, E. Stratton, M. Senna   +4 more
semanticscholar   +1 more source

Complementing baricitinib response in late-responding alopecia areata through alternating weekly double combination of topical corticosteroids: A split-scalp comparison [PDF]

JAAD Case Reports
Calogero Pagliarello, MD, PhD, Carlo Renè Girardelli, MD   +1 more
doaj   +2 more sources

Two Phase 3 Trials of Baricitinib for Alopecia Areata.

New England Journal of Medicine, 2022
BACKGROUND Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are limited.
B. King, M. Ohyama, O. Kwon, A. Zlotogorski, J. Ko, N. Mesinkovska, M. Hordinsky, Y. Dutronc, Wen-Shuo Wu, J. Mccollam, C. Chiasserini, G. Yu, S. Stanley, K. Holzwarth, A. DeLozier, Rodney D Sinclair   +15 more
semanticscholar   +1 more source

Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population

JAMA dermatology, 2023
Key Points Question What is the contemporary prevalence and incidence of alopecia areata (AA), alopecia totalis, and alopecia universalis in the US? Findings In this cohort study of a nationwide US employer-sponsored insurance population, AA prevalence ...
A. Mostaghimi, Wei Gao, M. Ray, Lauren Bartolome, Travis Wang, C. Carley, Nicolae Done, E. Swallow   +7 more
semanticscholar   +1 more source

Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Diagnosis and severity assessment

Przegląd Dermatologiczny, 2023
The existence of two types of alopecia areata is suggested (probably genetically different): early-onset, with more severe symptoms, longer disease duration, higher tendency to relapse, often with a positive family history, and late-onset, in which the ...
Adriana Rakowska, Lidia Rudnicka, Małgorzata Olszewska, Beata Bergler-Czop, Joanna Czuwara, Ligia Brzezińska-Wcisło, Joanna Narbutt, Waldemar Placek, Barbara Zegarska   +8 more
doaj   +1 more source

Alopecia Areata: An Updated Review for 2023

Journal of Cutaneous Medicine and Surgery, 2023
Alopecia areata is an immunemediated condition leading to nonscarring alopecia of the scalp and other hairbearing areas of the body. It affects up to 2% of the global population.1 It can affect all ages, but the prevalence appears higher in children ...
C. Sibbald
semanticscholar   +1 more source

Treatment of diseases associated with non-cicatricial alopecia

Przegląd Dermatologiczny, 2022
Alopecia (loss of volume or complete loss of hair) can be a symptom of many diseases. In some cases it is a symptom of a local pathology limited to the scalp, in others it is a dermatological symptom of a systemic pathology.
Lidia Rudnicka, Agnieszka Kaczorowska
doaj   +1 more source

Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Society of Dermatology. Part 2: Treatment

Przegląd Dermatologiczny, 2023
The treatment goal in alopecia areata is induction of hair regrowth and halting the progression of the disease. Treatment decisions depend on the severity of the alopecia areata as assessed by the Severity of Alopecia Tool (SALT) or the Alopecia Areata ...
Adriana Rakowska, Lidia Rudnicka, Małgorzata Olszewska, Beata Bergler-Czop, Joanna Czuwara, Ligia Brzezińska-Wcisło, Joanna Narbutt, Waldemar Placek, Barbara Zegarska   +8 more
doaj   +1 more source

Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics

Journal of Cosmetic Dermatology, 2021
Androgenetic alopecia (AGA) is the most common form of hair loss consisting of a characteristic receding frontal hairline in men and diffuse hair thinning in women, with frontal hairline retention, and can impact an individual's quality of life.
M. Nestor, G. Ablon, A. Gade, Haowei Han, Daniel L Fischer   +4 more
semanticscholar   +1 more source